A cross-sectional survey of COVID-19 testing status among vaccine recipients in Gombe, North-Eastern Nigeria

Author:

Sikiru Nafisah Ayinde1,Al-Mustapha Ahmad Ibrahim2,Oyewo Muftau3,Sani Bello Shittu1,Habibah Adeyi4,Alikinla Muftiat Mopelola5,Elelu Nusirat6

Affiliation:

1. Federal University of Kashere

2. University of Helsinki

3. Ministry of Agriculture and Rural Development

4. Okelele Secondary School Health Center

5. General Hospital Ilorin

6. Kwara State Primary Healthcare Development Board

Abstract

Abstract The COVID-19 testing status and vaccine acceptance are two key components of any COVID-19 control program as they are important in evaluating the prevalence of the disease as well as curbing the spread of the SARS-CoV-2, the causative agent of COVID-19. Hence, this study conducted a non-probability cross-sectional survey of 872 COVID-19 vaccine recipients in Gombe State to determine their testing status and socio-demographic profiles. The descriptive analysis revealed that the median age group was 30–39 years. More than half (57.7%, n = 503) of the study participants earned 50,000 Naira or less and approximately 51% of the vaccine recipients (n = 444) had tertiary education. Approximately one-third (35.1%, n = 306/872) of the study participants have been previously screened for SARS-CoV-2 and the COVID-19 positivity rate among them was 6.9% (n = 21/306). Some 108 (18.2%) persons reported Adverse Event Following Immunization (AEFI). The multivariable logistic regression analysis revealed that the age [30–39 years, (OR: 1.76; 95% CI: 1.13, 2.74; p = 0.041)], monthly income [150,000 naira and above (OR: 10.43; 95% CI: 2.22, 21.88; p < 0.001)], and background [health-related, (OR: 6.30; 95% CI: 4.35, 9.13; p = 0.01)] of the vaccine recipients was significantly associated with the COVID-19 testing status. The COVID-19 testing status of vaccine recipients is low. Hence, mass COVID-19 screening strategies should be implemented together with improved vaccine advocacy to focus on vaccine safety and efficacy.

Publisher

Research Square Platform LLC

Reference42 articles.

1. Impact of COVID‐19 on access to healthcare in low‐and middle‐income countries: current evidence and future recommendations;Okereke M;Int J Health Plann Manag,2021

2. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes;Togun T;Ann Clin Microbiol Antimicrob,2020

3. Worldometer COVID. Live - Coronavirus Statistics - Worldometer [Internet]. Worldometers.info. 2022 [cited 26 September 2022]. Available from: https://www.worldometers.info/coronavirus/. Accessed 26 September 2022.

4. Coronavirus NCDCNCDC. COVID-19 Microsite [Internet]. Covid19.ncdc.gov.ng. 2022 [cited 26 September 2022]. Available from: https://covid19.ncdc.gov.ng/. Accessed 26 September 2022.

5. Nigeria’s race to zero COVID-19 cases: True disease burden or testing failure?;Al-Mustapha AI;J global health,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3